---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-116985"
form_type: "8-K"
ticker: "KTTA"
cik: "0001841330"
company_name: "Pasithea Therapeutics Corp."
filed_at: "2025-12-02T23:59:59+00:00"
generated_at: "2026-05-16T15:46:23.799357+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Pasithea raises ~$60M in public offering of common stock and pre-funded warrants

## Summary
- Gross proceeds of $60.0M; net proceeds of ~$54.9M after fees and expenses.
- Offering priced at $0.75 per share/warrant; 80M shares (or pre-funded warrants) sold.
- Led by healthcare investors including Vivo Capital, Janus Henderson, Coastlands Capital.
- Insiders (CEO, CFO, board members) bought 400k shares at same price.
- Cash runway extended through at least first half 2028.

## SEC filing metadata
- accession: 0001213900-25-116985
- form_type: 8-K
- ticker: KTTA
- cik: 0001841330
- company_name: Pasithea Therapeutics Corp.
- filed_at: 2025-12-02T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841330/000121390025116985/0001213900-25-116985-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841330/000121390025116985/ea0267824-8k_pasithea.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-116985
- JSON: https://secwatch.observer/filing/0001213900-25-116985.json
- Plain text: https://secwatch.observer/filing/0001213900-25-116985.txt

## Key facts
- Equity Issuances
  Pasithea Therapeutics Corp. issued 4,000,000 shares of Common Stock of warrant to H.C. Wainwright & Co., LLC or its designees.
  - Security: warrant
  - Shares: 4,000,000 shares of Common Stock
  - Purchaser: H.C. Wainwright & Co., LLC or its designees
  source text: the Company issued to Wainwright or its designees, warrants (the “ Placement Agent Warrants ”) to purchase up to an aggregate of 4,000,000 shares of Common Stock (the “ Placement Agent Warrant Shares ”) at an exercise price equal to $0.9375 per share
  evidence_url: https://www.sec.gov/Archives/edgar/data/1841330/000121390025116985/0001213900-25-116985-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.